Published in JAMA on September 28, 2011
Implementation of a pilot accountable care organization payment model and the use of discretionary and nondiscretionary cardiovascular care. Circulation (2014) 1.56
Recommendations for optimal ICD codes to study neurologic conditions: a systematic review. Neurology (2012) 1.51
Enrollment volume effect on risk factor control and outcomes in the SAMMPRIS trial. Neurology (2015) 1.39
Readmissions after carotid artery revascularization in the Medicare population. J Am Coll Cardiol (2015) 1.39
The role of surgery in global health: analysis of United States inpatient procedure frequency by condition using the Global Burden of Disease 2010 framework. PLoS One (2014) 1.03
Online doctor reviews: do they track surgeon volume, a proxy for quality of care? J Med Internet Res (2012) 1.03
Comparison of carotid endarterectomy and stenting in real world practice using a regional quality improvement registry. J Vasc Surg (2012) 0.98
Factors Associated with Increased Rates of Post-procedural Stroke or Death following Carotid Artery Stent Placement: A Systematic Review. J Vasc Interv Neurol (2014) 0.87
Risk prediction for adverse events after carotid artery stenting in higher surgical risk patients. Stroke (2012) 0.86
Carotid artery stenting: review of technique and update of recent literature. Semin Intervent Radiol (2013) 0.85
An objective evaluation of a multi-component, competitive, selection process for admitting surgeons into higher surgical training in a national setting. World J Surg (2014) 0.79
The current management of carotid atherosclerotic disease: who, when and how? Interact Cardiovasc Thorac Surg (2012) 0.78
Volume, outcome, and policy. J Interv Card Electrophysiol (2012) 0.78
Hospital variation in rates of acid-reducing medication use after laparoscopic sleeve gastrectomy. Surg Obes Relat Dis (2015) 0.77
Carotid stenting at the crossroads: practice makes perfect, but some may be practicing too much (and not enough). JAMA (2011) 0.76
Selecting an appropriate surgical treatment instead of carotid artery stenting alone according to the patient's risk factors contributes to reduced perioperative complications in patients with internal carotid stenosis: a single institutional retrospective analysis. Neurol Med Chir (Tokyo) (2015) 0.75
Complication rates and center enrollment volume in the carotid revascularization endarterectomy versus stenting trial. Stroke (2014) 0.75
Outcomes of carotid artery stenting at a high-volume Brazilian interventional neuroradiology center. Clinics (Sao Paulo) (2015) 0.75
Regional variation in patient selection and treatment for carotid artery disease in the Vascular Quality Initiative. J Vasc Surg (2017) 0.75
Interhospital variation in reperfusion rates following endovascular treatment for acute ischemic stroke. J Neurointerv Surg (2014) 0.75
Physician age and outcomes in elderly patients in hospital in the US: observational study. BMJ (2017) 0.75
Evidence-Based Carotid Interventions for Stroke Prevention: State-of-the-art Review. J Atheroscler Thromb (2017) 0.75
Clinical Outcome of Carotid Artery Stenting According to Provider Specialty and Volume. Ann Vasc Surg (2017) 0.75
A comparison of clinical outcomes from carotid artery stenting among US hospitals. Circ Cardiovasc Qual Outcomes (2014) 0.75
Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med (2010) 17.57
Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med (2004) 12.58
Teaching surgical skills--changes in the wind. N Engl J Med (2006) 6.82
A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data. Med Care (2009) 5.13
Global experience in cervical carotid artery stent placement. Catheter Cardiovasc Interv (2000) 2.77
Early outcome of carotid angioplasty and stenting with and without cerebral protection devices: a systematic review of the literature. Stroke (2003) 2.63
Statistical assessment of the learning curves of health technologies. Health Technol Assess (2001) 2.60
Predictors of laparoscopic complications after formal training in laparoscopic surgery. JAMA (1993) 2.37
Clinical features and outcomes of carotid artery stenting by clinical expert consensus criteria: a report from the CARE registry. Catheter Cardiovasc Interv (2010) 2.21
Approval of virtual reality training for carotid stenting: what this means for procedural-based medicine. JAMA (2004) 2.21
Regional variation in carotid artery stenting and endarterectomy in the Medicare population. Circ Cardiovasc Qual Outcomes (2009) 2.21
Teaching procedural skills. BMJ (2008) 1.64
Assessment of the learning curve in health technologies. A systematic review. Int J Technol Assess Health Care (2000) 1.56
Appropriateness of learning curve for carotid artery stenting: an analysis of periprocedural complications. J Vasc Surg (2006) 1.22
Carotid artery stenting with neuroprotection: assessing the learning curve and treatment outcome. Am J Surg (2005) 1.15
Clinical competence statement on carotid stenting: training and credentialing for carotid stenting--multispecialty consensus recommendations: a report of the SCAI/SVMB/SVS Writing Committee to develop a clinical competence statement on carotid interventions. J Am Coll Cardiol (2005) 1.07
Carotid-artery stenting in stroke prevention. N Engl J Med (2010) 1.04
The good, the bad, and the about-to-get ugly: national trends in carotid revascularization: comment on "Geographic variation in carotid revascularization among Medicare beneficiaries, 2003-2006". Arch Intern Med (2010) 0.96
Use of virtual reality simulation for mission rehearsal for carotid stenting. JAMA (2007) 0.83
Evolution of carotid stenting: regulatory issues. Semin Vasc Surg (2008) 0.83
Carotid artery stenting with emboli protection surveillance study: outcomes at 1 year. J Am Coll Cardiol (2010) 0.82
Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med (2007) 25.17
Surgeon volume and operative mortality in the United States. N Engl J Med (2003) 16.97
Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA (2004) 14.05
Guest authorship and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation. JAMA (2008) 12.36
Exposure to low-dose ionizing radiation from medical imaging procedures. N Engl J Med (2009) 11.51
Telemonitoring in patients with heart failure. N Engl J Med (2010) 10.82
Variation in hospital mortality associated with inpatient surgery. N Engl J Med (2009) 9.39
Delayed time to defibrillation after in-hospital cardiac arrest. N Engl J Med (2008) 8.36
Strategies for reducing the door-to-balloon time in acute myocardial infarction. N Engl J Med (2006) 8.18
Door-to-balloon time and mortality among patients undergoing primary PCI. N Engl J Med (2013) 8.08
AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation (2006) 8.01
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2012) 7.94
Circumferential pulmonary-vein ablation for chronic atrial fibrillation. N Engl J Med (2006) 7.40
Nonvalidation of reported genetic risk factors for acute coronary syndrome in a large-scale replication study. JAMA (2007) 7.12
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation (2012) 6.94
Trends in hospital volume and operative mortality for high-risk surgery. N Engl J Med (2011) 6.90
Trial publication after registration in ClinicalTrials.Gov: a cross-sectional analysis. PLoS Med (2009) 6.89
Duration of resuscitation efforts and survival after in-hospital cardiac arrest: an observational study. Lancet (2012) 6.60
Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis. BMJ (2012) 6.39
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol (2011) 6.35
An administrative claims measure suitable for profiling hospital performance on the basis of 30-day all-cause readmission rates among patients with heart failure. Circ Cardiovasc Qual Outcomes (2008) 6.00
The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med (2005) 5.86
Sex-based differences in the effect of digoxin for the treatment of heart failure. N Engl J Med (2002) 5.74
Trends in survival after in-hospital cardiac arrest. N Engl J Med (2012) 5.67
Medical therapy to facilitate urinary stone passage: a meta-analysis. Lancet (2006) 5.65
Predictors of survival from out-of-hospital cardiac arrest: a systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes (2009) 5.65
Sex and racial differences in the management of acute myocardial infarction, 1994 through 2002. N Engl J Med (2005) 5.49
Imaging use among employed and self-employed urologists. J Urol (2010) 5.34
Diagnoses and timing of 30-day readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia. JAMA (2013) 5.27
National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998-2008. JAMA (2011) 5.16
Association of serum digoxin concentration and outcomes in patients with heart failure. JAMA (2003) 5.09
Hospital quality for acute myocardial infarction: correlation among process measures and relationship with short-term mortality. JAMA (2006) 5.06
Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation (2002) 4.99
Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction. JAMA (2002) 4.92
Reporting the recruitment process in clinical trials: who are these patients and how did they get there? Ann Intern Med (2002) 4.80
Surgical mortality as an indicator of hospital quality: the problem with small sample size. JAMA (2004) 4.76
National trends in use of computed tomography in the emergency department. Ann Emerg Med (2011) 4.72
The ADVANTAGE seeding trial: a review of internal documents. Ann Intern Med (2008) 4.70
Hospital lymph node examination rates and survival after resection for colon cancer. JAMA (2007) 4.55
Regulatory review of novel therapeutics--comparison of three regulatory agencies. N Engl J Med (2012) 4.50
Representation of the elderly, women, and minorities in heart failure clinical trials. Arch Intern Med (2002) 4.45
Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med (2006) 4.44
Consequences of inadequate sign-out for patient care. Arch Intern Med (2008) 4.39
Efficacy and safety of low-carbohydrate diets: a systematic review. JAMA (2003) 4.38
Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993-2006. JAMA (2010) 4.36
Risks associated with statin therapy: a systematic overview of randomized clinical trials. Circulation (2006) 4.35
Clostridium difficile ribotype does not predict severe infection. Clin Infect Dis (2012) 4.34
Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials. Lancet (2009) 4.31
Association of physician certification and outcomes among patients receiving an implantable cardioverter-defibrillator. JAMA (2009) 4.29
Reduction in acute myocardial infarction mortality in the United States: risk-standardized mortality rates from 1995-2006. JAMA (2009) 4.24
Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol (2004) 4.14
Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol (2006) 4.11
Role of intensive glucose control in development of renal end points in type 2 diabetes mellitus: systematic review and meta-analysis intensive glucose control in type 2 diabetes. Arch Intern Med (2012) 4.02
Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation: a new drug-drug interaction. Circulation (2003) 4.00
Recent national trends in readmission rates after heart failure hospitalization. Circ Heart Fail (2009) 3.95
Time to treatment in primary percutaneous coronary intervention. N Engl J Med (2007) 3.95
Long-term outcomes in elderly survivors of in-hospital cardiac arrest. N Engl J Med (2013) 3.85
Renal impairment and outcomes in heart failure: systematic review and meta-analysis. J Am Coll Cardiol (2006) 3.85
When choosing statin therapy: the case for generics. JAMA Intern Med (2013) 3.80
Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States: National Registry of Myocardial Infarction (NRMI)-3/4 analysis. Circulation (2005) 3.78
2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2008) 3.70
Association between stroke center hospitalization for acute ischemic stroke and mortality. JAMA (2011) 3.68
Complications, failure to rescue, and mortality with major inpatient surgery in medicare patients. Ann Surg (2009) 3.68